Vaxxinity Inc. (VAXX)
OTC: VAXX
· Real-Time Price · USD
0.05
0.02 (99.60%)
At close: Mar 26, 2025, 2:50 PM
Vaxxinity Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 5.04M | 17.39M | 37.06M | 22.59M | 33.48M | 18.88M | 109.07M | 124.77M | 144.88M | 89.38M | 110.84M | 49.14M |
Short-Term Investments | 25.46M | 25.12M | 18.79M | 44.99M | 53.35M | 80.23M | n/a | 3.47K | 869.00 | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | -80.15M | n/a | 78K | 172K | 74K | 58K | 98K |
Other Long-Term Assets | n/a | n/a | n/a | -1K | -84K | 82.23M | 2.08M | 1.35M | n/a | 6.26M | 2.79M | 3.12M |
Receivables | 414K | 407K | 407K | 518K | n/a | 400K | 400K | 399K | 393K | 380K | 372K | 366K |
Inventory | n/a | 206K | 2.75M | n/a | 6.12M | 1.75K | 12.2M | 7.83M | 8.51M | 1K | n/a | n/a |
Other Current Assets | 2.32M | 3.22M | 3.25M | 725K | 6.58M | 5.5M | 360K | 8.18M | 8.85M | n/a | n/a | 17.27M |
Total Current Assets | 33.23M | 46.36M | 59.7M | 73.43M | 93.89M | 108.08M | 122.02M | 133.35M | 154.13M | 104.05M | 127.45M | 66.4M |
Property-Plant & Equipment | 11.08M | 11.12M | 11.66M | 12.1M | 12.51M | 12.8M | 12.9M | 12.75M | 12.37M | 11.38M | 11.59M | 11.88M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13.22M | n/a | n/a |
Total Long-Term Assets | 11.08M | 11.12M | 11.66M | 12.1M | 12.51M | 14.88M | 14.97M | 14.18M | 12.54M | 30.86M | 14.44M | 15.09M |
Total Assets | 44.31M | 57.48M | 71.37M | 85.53M | 106.4M | 122.96M | 137M | 147.53M | 166.67M | 134.92M | 141.89M | 81.49M |
Account Payables | 1.78M | 2.97M | 1.89M | 3.03M | 5.29M | 3.32M | 338K | 1.46M | 3.19M | 3.9M | 5.88M | 8.26M |
Deferred Revenue | n/a | n/a | 20.5M | n/a | n/a | 28.7M | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.91M | 1.33M | 1.39M | 1.29M | 1.5M | 387K | 384K | 380K | 376K | 425K | 787K | 781K |
Other Current Liabilities | 1.56M | n/a | 2.61M | 1.53M | 11.37M | 12.05M | 2.31M | 5.78M | 4.52M | 5.13M | n/a | 3.55M |
Total Current Liabilities | 17.61M | 21.56M | 23.78M | 26.47M | 30.94M | 32.43M | 29.29M | 24.41M | 27.49M | 30.68M | 21.96M | 12.59M |
Long-Term Debt | 13.26M | 11.98M | 12.34M | 12.69M | 13.04M | 10.03M | 10.13M | 10.23M | 10.32M | 10.37M | 10.46M | 10.55M |
Other Long-Term Liabilities | 35K | 236K | 236K | 238K | n/a | n/a | n/a | 236K | 237K | 251.24M | 251.29M | 2.38M |
Total Long-Term Liabilities | 13.3M | 12.21M | 12.57M | 12.93M | 13.28M | 10.27M | 10.37M | 10.46M | 10.56M | 261.6M | 261.75M | 12.93M |
Total Liabilities | 30.9M | 33.77M | 36.35M | 39.4M | 44.22M | 42.7M | 39.66M | 34.87M | 38.05M | 292.28M | 283.71M | 25.52M |
Total Debt | 15.17M | 13.31M | 13.73M | 13.99M | 14.55M | 10.42M | 10.51M | 10.61M | 10.7M | 10.79M | 11.25M | 11.34M |
Common Stock | 278K | 279K | 279K | 279K | 278K | 278K | 278K | 278K | 278K | 255K | 255K | 249K |
Retained Earnings | -361.64M | -350.25M | -337.1M | -323.12M | -304.7M | -284.25M | -265M | -247.74M | -229.48M | -181.29M | -150.9M | -122.5M |
Comprehensive Income | 8K | -7K | -18K | -49K | -197K | -215K | n/a | 0.00 | n/a | -251M | -251.05M | 0.00 |
Shareholders Equity | 13.41M | 23.7M | 35.01M | 46.13M | 62.18M | 80.26M | 97.34M | 112.66M | 128.62M | -157.37M | -141.82M | 55.97M |
Total Investments | 25.46M | 25.12M | 18.79M | 44.99M | 53.35M | 81.56K | n/a | 78K | 172K | 74K | 58K | 98K |